Cargando…
Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors
Toxoplasma gondii is the causative agent of toxoplasmosis, a zoonotic disease that poses a threat to human health and a considerable loss to livestock farming. At present, clinical therapeutic drugs mainly target T. gondii tachyzoites and fail to eradicate bradyzoites. Developing a safe and effectiv...
Autores principales: | Chen, Min, Yang, Pei, Xin, Zixuan, Chen, Jiating, Zou, Weihao, Zhou, Lijuan, Yang, Lili, Peng, Jiao, Peng, Hongjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327641/ https://www.ncbi.nlm.nih.gov/pubmed/37426671 http://dx.doi.org/10.3389/fimmu.2023.1173379 |
Ejemplares similares
-
Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice
por: Wang, Jin-Lei, et al.
Publicado: (2017) -
Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth
por: Chen, Jiating, et al.
Publicado: (2022) -
Toxoplasma gondii Type-I ROP18 Targeting Human E3 Ligase TRIM21 for Immune Escape
por: Yao, Lijie, et al.
Publicado: (2021) -
Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice
por: Sun, Hong-chao, et al.
Publicado: (2023) -
Cloning, expression and immunoreactivity of recombinant Toxoplasma gondii GRA5 protein
por: Arab-Mazar, Zahra, et al.
Publicado: (2016)